inhibitors of Tyk2 and Jak1/2 (Genentech)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameinhibitors of Tyk2 and Jak1/2 (Genentech)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK2 inhibitorsTyrosine-protein kinase 2 inhibitorsTyrosine-protein kinase JAK1 inhibitors
TargetsTyrosine-protein kinase JAK2Tyrosine-protein kinase JAK1Tyrosine-protein kinase 2
Therapy Area/IndicationsPsoriasisInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenentech Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenentech Inc
Active IndicationsN/A
Inactive IndicationsPsoriasisInflammatory Bowel Diseases

Other Information

ATC CodeN/A
Related LinksN/A